PGV-1 is a potent antimitotic agent
Carcinogenesis can be involved in the malfunctioning of programmed cell death Most of the anticancer drug in current use induce apoptosis in susceptible cells. The fact that disparate agent interacting with different targets seem to induce cell death through some common mechanism suggest that anticancer activity is determined by the ability of inhibiting cell growth.
Pentagamavunon-1 (PGV-1) is one of the curcumin analogue which showed to have potency in inhibiting proliferation of human breast carcinoma cell T47D. The effect on T47D growth is associated with cell cycle arrest in G2/M phase at the concentration of 2.5 mM, followed by hyperploidy. Our data on polymerization assay, indicate PGV-1 interact with tubulin in different manner from taxol. PGV-1 inhibit tubulin polymerization on cell culture while taxol stabilized tubulin polymerization. Immunostainning data on cell treated with PGV-1 showed slightly tubulin condensation, while cell treated with taxol showed tubulin condensation distinctly at 12 minutes after releasing from depolymerization agent.
In conclusion, PGV-1 represent a new microtubule inhibitor and has the potential to be developed for anticancer drug
Key words: Pentagamavunon-1, T47D, tubulin, antimitotik
Aggarwal, B. B., Kumar, A, and Bharti, A. C., 2003b, Anticancer potential of curcumin: preclinical and clinical studies, Anticancer Res., 23(1A), 363-398.
Chow, Jermy, P. H., Siu, Yi, Wai., Fung, Ka, tsz., Chan, Mui, wan., Lau, Anita., arooz, Talha., Ng, Chuen-Pei., Yamashita, Katsumi., Poon, and Randy, Y. C., 2003, DNA Damage During The Spindle-Assembly Checkpoint Degrades CDC25A, Inhibit Cyclin-CDC2 Complexes, and Reverses Cells to Interphase., Molecular Biology of The Cell, Vol. 14, 3980-4002
Da’i, M., Jenie AJ., Kawaichi M., Supardjan, A.M., and Meiyanto, E,, 2007, T47D cells arrested at G2M and Hyperploidy Formation Induced by a Curcumin’s Analogue PGV-1, submitted for publication
Hadfield, John, A., Ducki, Sylvie., Hirst, Nicholas., McGown, and Alan, T., 2003. Tubulin and Microubule as targets for Anticancer Drugs., Progress in Cell Cycle Research, Vol. 5, 309-325
Jordan, Alan., Hadfield, John, A., Lawrence, Nicholas, J., McGown, and Alan, T.1998 . Tubulin as a Target for Anticancer Drugs: Agents which Interact with the Mitotic Spindle. Med Res Rev, 18:4, 259-296
Ling, Xiang Ling, Cheng, Qiuying, Black., j.D, li, and Fengzhi, 2007, Forced expression of surviving-2B abrogates mitotic cells and induces mitochondria-dependent apoptosis by blockade of tubulin polymerization and Modulation of Bcl-2, Bax and surviving. Journal of Biological Chemistry, V0l. 282. No 37. 27204-27214
Okada, H., and Mak, T.W., 2004, Pathways of Apoptosis and Non Apoptotic Detah in Tumour Cells, Cancer, 4, 592-603
Park, M. J., Kim, E. H., Park, I. C., Lee, H. C., Woo, S. H., Lee, J. Y., Hong, Y. J., Rhee, C. H., Choi, S. H., Shim, B. S., Lee, S. H., and Hong, S. I., 1998, Curcumin inhibits cell cycle progression of immortalized human umbelical vein endhotelial (ECV304) cells by up regulating cyclin dependent kinase inhibitor, p21WAF1/CIP1, p27Kip1 and p53, International Journal of Oncology, 21: 379-383
Usui, Takeo., Kondoh, Masuo., Cui, Cheng-Bin., Mayumi, Tadanori., Osada, and Hiroyuki, 1998., Tryprostatin A, a Specific and Novel Inhibitor of Microtubule Assembly., Biochem. J., 333, 543-548
Wang T. H., Wang, H, S., Ichijo, H., Giannakakou, P., Foster, J. S., Fojo, T., and Wimalasena, J., 1998, Microtubule-interacting agents activate c-Jun N-Terminal kinase/stressactivated protein kinase through both Ras and apoptosis signal regulating kinase pathways, J Biol Chem, 273, 4928
Wang, T. H., Wang, H.S., Soong, Y. K., 2000, Paclitaxel Induced Cell Death: Where The Cell Cycle and Apoptosis Come Together, Cancer, 11, 2619-2628
Wolanin, Kamilla, Magaiska, A., Mosieniak, G., Klinger, Rut, Mckenna, Sharon, Vedja, S, Ewa, Sikora, and Piwocka, K., 2006, Curcumin Affects Component of Chromosomal Passenger Complex and Induces Mitotic Catastrophe in Apoptosis-Rsistant Bcr-Abl-Expressing Cells, Mol Cancer res, 4 : 7, 457-469
Zhang, Li-Hua, Wu, Lei., Raymon, K. H., Chen, R. S., Corral, Laura., Shirley, M. A., Narla, Krisna Rama., Games, Jim., Muller, George W., Stirling, D.I., Bartlet, J.B., Schafe, P.H., Payvandi, and Faribourz, 2006. The Synthetic Compound CC-5079 Is a Potent Inhibitor of Tubulin Polymerization and Tumour Necrosis factor-a Production with Antitumor Activity. Cancer Res :66 : 2, 951-960
- There are currently no refbacks.
Copyright (c) 2017 INDONESIAN JOURNAL OF PHARMACY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Indonesian J Pharm indexed by:View My Stats